O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

O-I Glass, Inc.

Glass Health

Glass Health is thrilled to announce our $5M seed round led by Initialized Capital. 🎉

Our latest funding will further our mission to empower clinicians with generative AI for clinical decision support.

We’re proud to count prominent healthcare founders as mentors and investors in this seed round, including Tom Lee, founder of One Medical, Epocrates, and Galileo Health; Connor Landgraf, founder of Eko Health; and Heather Hasson & Trina Spear, the co-founders of FIGS.

https://lnkd.in/gfA9xW6w

#Y Combinator #Breyer Capital #Initialized Capital

Our Glass AI CDS platform has been upgraded with a new core feature...🥁🎁

Glass Consult is our NEW clinical reference chatbot✨

Consult uses physician-validated context to answer clinical reference questions with in-text references at glass.health🎊🦾

Check out Glass Consult in action above, featuring physician-validated context on Acute Appendicitis by Glass Health AI Clinical Fellows & AI Editors, Marianne Ruelle, MD; Deven Patel, MD; & Gurbani Kaur, MD

#AI #AICDS #healthcareinnovation #healthcaretechnology #aiinhealthcare 

Y Combinator Initialized Capital

Tomorrow is almost here...

#healthcareinnovation #ai #healthcare #healthcaretechnology #AICDS

Introducing History & Physical Mode! 

Clinicians, we heard your request for better handling of complex cases by Glass AI. Starting today, you can input a full H&P to draft AI-assisted differential diagnoses and clinical plans. 

Try H&P Mode now at http://glass.health

This update includes major upgrades to the Glass user interface and its ability to assist with differential diagnosis and clinical plan drafting. Clinical training of Glass AI is ongoing by the Glass Health team of academic clinical contributors.

Glass AI is an experimental product in development. Given ongoing development and LLM limitations, all AI results should be supervised at the level of a trainee, interpreted cautiously, and should never replace clinician knowledge or judgment.

#healthcareinnovation #ai #aiinhealthcare Y Combinator

Glass Health's mission to empower clinicians with AI-assisted diagnosis and clinical decision-making is featured in this recent piece by the World Economic Forum 🏥 

https://lnkd.in/ehQa48Mk

🎊 New Updates to Glass AI🎊

The Glass Health team has trained Glass AI to draft clinical plans for new topics!

Check out our new handling of...
- hypoxemia
- hemoptysis
- community-acquired PNA

We're also sharpening Glass AI's ability to develop a DDx for high-yield medicine topics, including:

- hypoxemia
- constipation
- TIA
- UTI.

Just try entering a one-liner at http://glass.health. Glass AI will suggest 5 potential diagnoses to consider.

#ai #healthcare #healthtech #medicine Y Combinator Dereck Paul, MD Graham Ramsey

🚨 NEW Version of Glass AI Available 🚨 

Glass AI 2.0 combines an LLM with a clinical knowledge database created by our clinician team.

With clinician training, we create better DDx and Clinical Plan outputs than base LLMs.

Try 2.0 now at http://glass.health/ai

Clinicians have trained Glass AI 2.0 for this first release on a select group of high-yield medical topics.

Training is ongoing and you can view the full list of medical topics included in this release within the product.

Glass AI is in development to assist clinicians with differential diagnosis, evidence-based Tx, and documentation.

We make advances with your feedback and thank the community who has used Glass AI 1.0 over the past few weeks.

Please remember, Glass AI is a reference tool and assistant, like a smart textbook. It does not replace clinician judgment and should always be supervised.

Notably, Glass AI was not created for the general public and does not generate general advice medical advice.

Today's release of Glass AI 2.0 is the collective effort of the incredible Glass AI Clinical Contributor team. Full credits within the Glass AI tab in the Glass platform.

cc: Dereck Paul, MD, Graham Ramsey, Y Combinator, Breyer Capital

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 3:34 PM	73ef0eff
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 3:34 PM	4e08cd72
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 8, 2024 3:34 PM	a82df14b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:O-I

Glass Health

Last Close

12.85

22/11 21:00

Market Cap

2.00B

Beta: -

Volume Today

974.14K

Avg: -